ATNAA
SPE2DP-26-D-0001 · DEPT OF DEFENSE
A BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING solicitation, performed in Philadelphia, PA, with responses due 2026-10-02. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Antidote Treatment Nerve Agent Auto-Injector Request For Information (RFI) This RFI does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to this announcement. Item: ANTIDOTE TREATMENT, NERVE AGENT, Automatic, Dual-Chamber, Pralidoxim
Comparable recent awards in BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| JACKSON LABORATORY | $3.0M | 1 | 2026-07-01 |
| BANNER HEALTH | $30K | 1 | 2026-06-26 |
| BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE | $3.7M | n/a | 2026-06-26 |
| LIFE TECHNOLOGIES CORPORATION | $51K | 1 | 2026-06-26 |
| REPROCELL U.S.A., INC. | $32K | 1 | 2026-06-22 |
Questions
What is solicitation SPE2DP-26-D-0001?
ATNAA, issued by DEPT OF DEFENSE, under NAICS 325414 (BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING), performed in Philadelphia, PA. Responses are due 2026-10-02.
What do similar contracts close for?
Comparable closed awards in this category ran from $30K to $3.7M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is SPE2DP-26-D-0001 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.